Race-Specific Drug 'BiDil': Nitromed's Marketing Challenge |
ICMR HOME | Case Studies Collection Please note: This case study was compiled from published sources, and is intended to be used as a basis for class discussion. It is not intended to illustrate either effective or ineffective handling of a management situation. Nor is it a primary information source. |
||||
Excerpts Contd...Nitromed's Marketing Initiatives for BiDil
Problems for BiDilPrior to receiving the approval from FDA, NitroMed predicted that the sales of BiDil would touch US$ 120 million in the first year itself and within a few years would cross the US$ 1 billion mark per annum. When BiDil was launched, some analysts expected BiDil sales to touch US$ 200 million by 2007. For instance, Deutsche Bank North America analyst Jennifer Chao projected that BiDil would reach US$192 million in sales in 2007.
Exhibits
Exhibit I: BiDil and African Americans |
Case Studies Links:-
Case Studies,
Short Case Studies,
Simplified Case Studies.
Other Case Studies:-
Multimedia Case Studies,
Cases in Other Languages.
Business Reports Link:-
Business Reports.
Books:-
Text Books,
Work Books,
Case Study Volumes.